除了肉瘤中心之外:建立肉瘤HASM网络 - - 一个全球综合和精确护理中心的Hub and Spoke Model网络
1Sarcoma Center/IPU, Department of Orthopaedics and Trauma, LUKS University Hospital, Lucerne; Faculty of Health Research & Medicine, University of Lucerne, Lucerne, Switzerland.
ESMO open
|December 6, 2024
概括
一个新的瘤中心和口腔模型 (HASM) 网络改善了瘤护理协调和获取. 该模型使用数字平台和数据仓库来实现个性化治疗和全球更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
- 医疗信息学 医疗信息学
背景情况:
- 瘤治疗已经从截肢演变为节约四肢的手术,由多学科方法驱动.
- 专门的肉瘤中心已经改善了护理,但可访问性和专业知识仍然是挑战.
- 现有的模型很难提供公平的机会获得专门的肉瘤专业知识.
研究的目的:
- 提出"瘤中心和口腔模型" (HASM) 网络,以应对瘤护理可访问性和协调方面的挑战.
- 概述一个框架,以优化资源分配和以患者为中心的护理服务在肉瘤治疗.
- 引入一个集成数字平台和数据分析的模型,以实现个性化的肉瘤管理.
主要方法:
- 在HASM网络中集中复杂的病例在"中心"和常规诊断/治疗在"线索".
- 整合数字互操作平台,实现实时数据交换和多学科团队支持.
- 利用先进的分析,包括 Sarcoma 数字双胞胎和因果机器学习,使用 Sarcoma Care 数据仓库.
主要成果:
- 该HASM模型优化了资源利用,并提高了获得专门的瘤专业知识的机会.
- 数字平台促进了无的数据共享,改善了多学科团队的协作.
- 预测分析和数据仓储使个性化治疗策略和质量评估成为可能.
结论:
- 拟议的HASM网络代表了标准化和提升全球肉瘤护理的创新方法.
- 利用技术和协作网络可以克服专业化癌症治疗的现有障碍.
- 该模型旨在通过加强协调,数据利用和个性化医疗来改善患者的治疗结果.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


